Abstract
Onychomycosis is a common nail fungal infection. Patients with onychomycosis may experience discomfort and pain caused by a variety of nail abnormalities, such as discoloration, subungual hyperkeratosis, onycholysis, splitting and nail plate destruction. Currently there are four onychomycosis treatments available in Canada (ciclopirox, efinaconazole, itraconazole and terbinafine). This research aims to explore switch patterns among treatments of onychomycosis patients in Canada.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
